UltraSight 融资 2400 万美元，扩展 AI 心脏超声引导业务
UltraSight Secures $24M to Scale Point-of-Care Cardiac Ultrasound Across Health Systems
一家做 AI 心脏超声引导的公司 UltraSight 拿了 2400 万美元 B2 轮，让非专科医生也能在床旁做心脏彩超，Mayo Clinic 还在跟投。
UltraSight 宣布完成 2400 万美元 B2 轮融资，由 Alive HealthTech Growth Fund 领投。Deep Insight、Star51 Capital、Connecticut Innovations 和 eHealth Ventures 联合投资。Mayo Clinic Ventures 和 NYU 等现有投资方继续参与。公司将用这笔资金扩大 AI 引导心脏超声工作流在各医疗系统中的应用。
UltraSight Secures $24M to Scale Point-of-Care Cardiac Ultrasound Across Health Systems
What You Should Know UltraSight™, a pioneer in AI-guided cardiac ultrasound workflows, announced it raised $24M in Series B2 financing. Alive HealthTech Growth Fund led the funding round, with co-investment from Deep Insight, Star51 Capital, Connecticut Innovations, and eHealth Ventures, and participation from existing clinical and venture stakeholders, including Mayo Clinic Ventures, NYU, and Iron ... Read More
